India Exchange Filings

Ajanta Pharma Revised Pledge Disclosure

Ajanta Pharma Ltd trustee revises pledge disclosures covering 4.9 lakh shares for acquisition funding

  • Aayush Agrawal, trustee of Aayush Agrawal Trust, submitted the revised SEBI SAST disclosures; letter dated 16 November 2026.
  • Pledges cover 4.6 lakh shares (0.37%) created on 28 September 2026 and 30,000 shares (0.02%) created on 15 October 2026.
  • Revision adds the lender’s name as an entity in whose favour the shares are encumbered; other disclosure details are unchanged.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.